Formulation of Pharmaceuticals and Biologics - Chair: Ulla Elofsson

C-43 - Dr Grit Baier, BASF - FORMULATION OF ENZYMES FOR INDUSTRIAL APPLICATIONS
C-47 - Sebastian Hansson, SOLVE Research & Consultancy AB - LABEL-FREE CHARACTERISATION OF BIOLOGICAL DRUGS IN PLASMA
C-13 - Chi Zhang, University of Manchester - FORMULATION OF ENVIRONMENTALLY FRIENDLY COSMETIC CREAMS
C-27 - Dr Martin Edwards, Britest Limited - A SYSTEMS-BASED APPROACH TO DIGITAL DESIGN AND OPERATION IN THE FORMULATION OF PHARMACEUTICALS
C-33 - Dr Alison Savage, University of Liverpool - FORMULATION OF DUAL COMPONENT SOLID DRUG NANOPARTICLES FOR IMPROVED ORAL BIOAVAILABILITY OF DARUNAVIR AND RITONAVIR
C-46 - Prof Alain Durand, Université de Lorraine CNRS - CHARACTERIZATION OF COMMERCIAL PHARMACEUTICAL TABLETS AND MODEL BINARY MIXTURES TOWARD AN IMPROVED UNDERSTANDING OF TREATMENT EFFICIENCY